OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Haloperidol Metabolite II Valproate Ester (S)-(−)-MRJF22: Preliminary Studies as a Potential Multifunctional Agent Against Uveal Melanoma
Carla Barbaraci, Giovanni Giurdanella, Claudia Giovanna Leotta, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13622-13632
Open Access | Times Cited: 11
Carla Barbaraci, Giovanni Giurdanella, Claudia Giovanna Leotta, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13622-13632
Open Access | Times Cited: 11
Showing 11 citing articles:
In vitro and in vivo studies of ocular topically administered NLC for the treatment of uveal melanoma
Cinzia Cimino, Elena Sánchez-López, Angela Bonaccorso, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124300-124300
Open Access | Times Cited: 7
Cinzia Cimino, Elena Sánchez-López, Angela Bonaccorso, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124300-124300
Open Access | Times Cited: 7
Repurposing Antipsychotics for Cancer Treatment
Nikolaos Vlachos, Marios Lampros, Spyridon Voulgaris, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1785-1785
Open Access | Times Cited: 33
Nikolaos Vlachos, Marios Lampros, Spyridon Voulgaris, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1785-1785
Open Access | Times Cited: 33
HDAC/σ1R Dual-Ligand as a Targeted Melanoma Therapeutic
Claudia Giovanna Leotta, Carla Barbaraci, Jole Fiorito, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 179-179
Open Access
Claudia Giovanna Leotta, Carla Barbaraci, Jole Fiorito, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 179-179
Open Access
Nanostructured lipid carrier for the ophthalmic delivery of haloperidol metabolite II valproate ester (±)-MRJF22: A potential strategy in the treatment of uveal melanoma
Cinzia Cimino, Claudia Giovanna Leotta, Agostino Marrazzo, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104811-104811
Open Access | Times Cited: 8
Cinzia Cimino, Claudia Giovanna Leotta, Agostino Marrazzo, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 87, pp. 104811-104811
Open Access | Times Cited: 8
Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands
Maria Dichiara, Francesca Alessandra Ambrosio, Carla Barbaraci, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 10, pp. 1845-1858
Open Access | Times Cited: 6
Maria Dichiara, Francesca Alessandra Ambrosio, Carla Barbaraci, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 10, pp. 1845-1858
Open Access | Times Cited: 6
Development of l-Dopa-containing diketopiperazines as blood-brain barrier shuttle
Catia Cornacchia, Lisa Marinelli, Annalisa Di Rienzo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114746-114746
Open Access | Times Cited: 9
Catia Cornacchia, Lisa Marinelli, Annalisa Di Rienzo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 243, pp. 114746-114746
Open Access | Times Cited: 9
Discovery of first novel sigma/HDACi dual-ligands with a potent in vitro antiproliferative activity
Carla Barbaraci, Viviana di Giacomo, Annalisa Maruca, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106794-106794
Open Access | Times Cited: 5
Carla Barbaraci, Viviana di Giacomo, Annalisa Maruca, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106794-106794
Open Access | Times Cited: 5
Structure-activity relationships of mixed σ1R/σ2R ligands with antiproliferative and anticancer effects
Antonino N. Fallica, Valeria Ciaffaglione, Maria Modica, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117032-117032
Closed Access | Times Cited: 4
Antonino N. Fallica, Valeria Ciaffaglione, Maria Modica, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 73, pp. 117032-117032
Closed Access | Times Cited: 4
Understanding choroidal nevus risk factors for transformation into melanoma
Joseph D. DeSimone, Charlotte N. Shields, Nicholas E. Kalafatis, et al.
Clinics in Dermatology (2023) Vol. 42, Iss. 1, pp. 38-45
Closed Access | Times Cited: 2
Joseph D. DeSimone, Charlotte N. Shields, Nicholas E. Kalafatis, et al.
Clinics in Dermatology (2023) Vol. 42, Iss. 1, pp. 38-45
Closed Access | Times Cited: 2
Design, synthesis and antitumor activity evaluation of pyrimidine derivatives containing 4-hydroxypiperidine group
Lingling Chi, Hao Wang, Fuqiang Yu, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 10, pp. 2125-2137
Closed Access | Times Cited: 1
Lingling Chi, Hao Wang, Fuqiang Yu, et al.
Medicinal Chemistry Research (2023) Vol. 32, Iss. 10, pp. 2125-2137
Closed Access | Times Cited: 1
Development of L-Dopa-Containing Diketopiperazines as Blood-Brain Barrier Shuttle
Catia Cornacchia, Lisa Marinelli, Annalisa Di Rienzo, et al.
SSRN Electronic Journal (2022)
Closed Access
Catia Cornacchia, Lisa Marinelli, Annalisa Di Rienzo, et al.
SSRN Electronic Journal (2022)
Closed Access
